Search results for: 'Conversation AI in Healthcare'

The MedTech industry until 2040 encompasses groundbreaking integrations of artificial intelligence (AI), biotechnology, regenerative therapies, nanomedicine, and sustainable digital ecosystems to redefine preventive, personalized, and precision healthcare. These advancements enable real-time genomic editing, implantable biosensors for continuous mo...

This study examines the development prospects that artificial intelligence (AI) offers the commercial vehicle (CV) industry, focusing on both the revolutionary potential of AI and the difficulties businesses face in fostering growth, including complicated regulations, high capital expenditure, and challenges in incorporating new technology into pre...

26 Aug 2022  |  Global  |  Market Research

Artificial Intelligence (AI) in Agriculture: Global Growth Opportunities

AI Adoption in Agriculture will Create New Business Growth Opportunities

Infographics

×

In this research service, Frost & Sullivan analyzes the core capabilities of AI technology in the agriculture industry. The study examines the growth environment that drives new use-cases and greater adoption as AI-based solutions are adding new value to ​​farming operations. The core essence of digital agriculture practices is to create actionable...

This Frost Radar™ analyzes conversational AI vendors in the patient engagement space that enable healthcare organizations to improve their efficiency, efficacy, and engagement of one of their significant cost centers. The market is evolving from focal performance capability either in administrative workflows or contact centers to platform capabilit...

HIMSS 2026, held in Las Vegas, brought together 24,000+ stakeholders and 900+ exhibitors, underscoring the growing urgency for healthcare organizations to translate digital investments into measurable outcomes amid cost pressures, workforce shortages, and rising care complexity. Discussions at the event highlighted a clear shift from innovation-led...

The story for 2024 is artificial intelligence (AI). Businesses across industries are scrambling to determine how they can leverage AI, particularly generative AI (GenAI), to meet their business goals. Public cloud providers are at the forefront of the effort to accelerate AI adoption among customers by developing foundational models and user-friend...

Industrial manufacturing faces unprecedented disruption from equipment downtime, skills shortages, and volatile trade policies, while legacy systems struggle to integrate with modern AI. Fortune 500 companies lose significant revenue each year to unplanned downtime. At the same time, manufacturers face margin compression from tariff volatility and ...

09 Sep 2024  |  Global  |  Technology Research

AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029

AI-based Drug Repurposing is emerging as a new and faster approach to bringing drugs to patients.

Infographics

×

This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across dif...

This Frost & Sullivan analysis examines the clinical next-generation sequencing (NGS) industry, covering the different type of products, workflows, and applications for clinical purposes. The global market is projected to grow steadily from 2024 to 2030, achieving significant revenue milestones, driven largely by services and informatics segments. ...